NCT00004647View on ClinicalTrials.gov

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mexiletine for Painful Diabetic Neuropathy

PHASE3CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

March 31, 1993

Study Completion Date

February 28, 1999

Conditions

PainDiabetic NeuropathiesParesthesia

Interventions

DRUG

mexiletine

All Listed Sponsors

collaborator

University of Tennessee

OTHER

lead

National Center for Research Resources (NCRR)

NIH